Measurement device

US2023355181A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2023355181-A1
Application numberUS-202318222739-A
CountryUS
Kind codeA1
Filing dateJul 17, 2023
Priority dateNov 4, 2008
Publication dateNov 9, 2023
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An insulin infusion device includes a cannula for infusing insulin under the skin and an insulin infusion section for storing therein insulin to be delivered to the cannula. The insulin infusion device also includes a motion measurement section that measures the tilt angle or rotation angle of a center axis of the insulin infusion section from a neutral position thereof, or vibration applied to the insulin infusion section, to output a measured value as motion information of living activity. The insulin infusion device also includes a controlling section that controls, based on the motion information, a process of notifying a user of the timing or recommended direction of priming of the insulin infusion section.

First claim

Opening claim text (preview).

What is claimed is: 1 . An insulin infusion device comprising: a cannula for infusing insulin under the skin; an insulin infusion section for storing therein insulin to be delivered to the cannula; a motion measurement section that measures the tilt angle or rotation angle of a center axis of the insulin infusion section from a neutral position thereof, or vibration applied to the insulin infusion section, to output a measured value as motion information of living activity; and a controlling section that controls, based on the motion information, a process of notifying a user of the timing or recommended direction of priming of the insulin infusion section. 2 . The insulin infusion device according to claim 1 , further comprising a recording section that records therein the motion information. 3 . The insulin infusion device according to claim 2 , further comprising a communication section that transmits the motion information recorded in the recording section. 4 . The insulin infusion device according to claim 2 , further comprising a display section that displays thereon the motion information recorded in the recording section. 5 . The insulin infusion device according to claim 1 , further comprising: a biosensor which selectively responds to a specific analyte in a biological fluid for detecting the presence or concentration of the analyte in the biological fluid; an analyte measurement section that measures a characteristic amount of the analyte with the biosensor; and a recording section that records therein the motion information and the characteristic amount with the motion information and the characteristic amount associated with each other. 6 . The insulin infusion device according to claim 5 , wherein the biosensor is a continuous glucose monitoring sensor to be inserted under the skin. 7 . The insulin infusion device according to claim 5 , wherein the biosensor is a blood glucose sensor for measuring blood glucose level. 8 . The insulin infusion device according to claim 1 , further comprising a pump section for delivering insulin stored in the insulin infusion section to the cannula, wherein the controlling section estimates, based the operation time of the pump section, the quantity of insulin being delivered by continuous subcutaneous insulin infusion or the quantity of the last bolus that is still active in the body (insulin on board), and records the estimated quantity in the recording section. 9 . The insulin infusion device according to claim 1 , further comprising a living activity calculation section that calculates, based on the motion information, living activity level in terms of METs.

Assignees

Inventors

Classifications

  • A61B5/721Primary

    using a separate sensor to detect motion or using motion information derived from signals other than the physiological signal to be measured · CPC title

  • characterised by the type of physiological signal transmitted · CPC title

  • for measuring glucose, e.g. by tissue impedance measurement · CPC title

  • using enzyme electrodes, e.g. with immobilised oxidase · CPC title

  • invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2023355181A1 cover?
An insulin infusion device includes a cannula for infusing insulin under the skin and an insulin infusion section for storing therein insulin to be delivered to the cannula. The insulin infusion device also includes a motion measurement section that measures the tilt angle or rotation angle of a center axis of the insulin infusion section from a neutral position thereof, or vibration applied to…
Who is the assignee on this patent?
Phc Holdings Corp
What technology area does this patent fall under?
Primary CPC classification A61B5/721. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Nov 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).